An analysis of clinical samples from CCA patients revealed that patients with CCA have increased serotonin in the bile, along with increased expression of tryptophan hydroxylase, which is responsible for the synthesis of 5-hydroxytryptamine, and decreased expression of monoamine oxidase A, which is responsible for the degradation of 5-hydroxytryptamine. This evidence concerns the gene MAOA and cholangiocarcinoma.